Tuesday, February 10, 2026

This Founder Is Taking a Bite Out of the $50 Billion GLP-1 Market By Going Natural

As pharmaceutical companies race to scale synthetic GLP-1s, Evolv is betting that consumers want a natural, orally available version.

source https://www.entrepreneur.com/business-news/this-founder-built-natural-glp-1-alternative-before-the-boom/502567

No comments:

Post a Comment